Homburger advised Yoda, a Cyprus-based investment corporation, on its investment into Ultima Capital, a Swiss luxury real estate owner, advised by Baker McKenzie Switzerland. Yoda reached an agreement with Ultima and with another new investor
Tags :Oliver Kneubühl
Competition & Antitrust
Corporate
Lenz & Staehelin: Vencora announces PTO for Crealogix publicly held
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an
Dufry has successfully closed the transfer of the 50.3% stake in Autogrill held by Edizione through a wholly owned subsidiary to Dufry. Dufry will launch a mandatory public exchange offer for the remaining Autogrill shares (excluding
H.I.G. Capital, a leading global investment firm with USD 52 bn of equity capital under management, announced that one of its affiliates has completed the acquisition of Celerion Holdings, a leading full-service provider of
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at
The Berlin-based insurtech wefox Holding has announced that it has successfully reached an agreement for its Series D funding round, increasing its post-money valuation to USD 4.5 bn. The equity round was led by Mubadala Investment
Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
VectivBio Holding a clinical-stage biopharmaceutical company, has announced a combined gross proceeds from public offering and private sale of USD 50 million. On one side, the company has announced the pricing of a follow-on public offering
The team was led by partners Dieter Gericke (Corporate | M&A) and Jürg Frick (Banking and Finance - pictured) and comprised Stefan Oesterhelt (Tax)
